Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Feb 12, 2021
Finance
Public listing, Phase II cancer readouts in Cyteir’s sights as it banks $80M crossover round
...RA Capital in the round were Janus Henderson Investors, Acuta Capital Partners, Ally Bridge Group,
Avidity Partners
...
Read More
BioCentury
|
Dec 17, 2020
Finance
Dec. 16 Quick Takes: Neurogene raises $115M while BioAtla sees first-day pop; plus fundings for Atsena, MinervaX, Vivace, Arvinas
...Samsara BioCapital and Cormorant Asset Management. New investors include BlackRock, Janus Henderson Investors, Casdin Capital,
Avidity Partners
...
Read More
BioCentury
|
Oct 21, 2020
Deals
With roots in Medivation, Nuvation finds quick route to listing via year’s largest SPAC deal
...$175 million on Wednesday.Other investors in Nuvation’s PIPE include new investors 683 Capital, Ally Bridge,
Avidity Partners
...
Read More
BioCentury
|
Sep 15, 2020
Finance
Sept. 14 Quick Takes: $70M+ rounds for Escient, Escape, plus Alzheimer’s data lifts Cassava shares and more
...$73 million in a crossover round led by Wellington Management Company LLP. Additional new investors
Avidity Partners
...
Read More
BioCentury
|
Sep 5, 2020
Deals
Deal with AbbVie, PIPE triples I-Mab’s cash, positions biotech to be among China’s CD47 leaders
...June 30, I-Mab had $221.1 million in cash and restricted cash.Other investors in the PIPE included
Avidity Partners
...
Read More
BioCentury
|
Aug 19, 2020
Finance
Aug. 18 Quick Takes: Chinook fuels up for NASDAQ liftoff; plus Kymera, Poseida, Albireo
...New investors in the kidney disease company include EcoR1 Capital, OrbiMed Advisors, Rock Springs Capital,
Avidity Partners
...
Read More
BioCentury
|
Jun 16, 2020
Finance
June 15 Quick Takes: RA makes $200M investment in Novavax; plus venture rounds for Shattuck, ImmVira, Glyscend and Shukun
...Group, with participation from new investors Janus Henderson Investors, Fidelity, EcoR1 Capital, Hatteras Venture Partners,
Avidity Partners
...
Read More
BioCentury
|
Jun 5, 2020
Finance
With $85M series B, Athira seeks to recover neuronal health in Alzheimer’s patients
...Capital, Highside Capital Management, Logos Capital, funds managed by Janus Henderson Investors, Sofinnova Investments and
Avidity Partners
...
Read More
BioCentury
|
Feb 28, 2020
Finance
Verastem raises $100M, plots path forward with targeted cancer combo
...The syndicate included RA Capital, Vivo Capital, Venrock, Farallon Capital Management, Acuta Capital, EcoR1 Capital,
Avidity Partners
...
Read More
Items per page:
10
1 - 9 of 9
BioCentury
|
Feb 12, 2021
Finance
Public listing, Phase II cancer readouts in Cyteir’s sights as it banks $80M crossover round
...RA Capital in the round were Janus Henderson Investors, Acuta Capital Partners, Ally Bridge Group,
Avidity Partners
...
Read More
BioCentury
|
Dec 17, 2020
Finance
Dec. 16 Quick Takes: Neurogene raises $115M while BioAtla sees first-day pop; plus fundings for Atsena, MinervaX, Vivace, Arvinas
...Samsara BioCapital and Cormorant Asset Management. New investors include BlackRock, Janus Henderson Investors, Casdin Capital,
Avidity Partners
...
Read More
BioCentury
|
Oct 21, 2020
Deals
With roots in Medivation, Nuvation finds quick route to listing via year’s largest SPAC deal
...$175 million on Wednesday.Other investors in Nuvation’s PIPE include new investors 683 Capital, Ally Bridge,
Avidity Partners
...
Read More
BioCentury
|
Sep 15, 2020
Finance
Sept. 14 Quick Takes: $70M+ rounds for Escient, Escape, plus Alzheimer’s data lifts Cassava shares and more
...$73 million in a crossover round led by Wellington Management Company LLP. Additional new investors
Avidity Partners
...
Read More
BioCentury
|
Sep 5, 2020
Deals
Deal with AbbVie, PIPE triples I-Mab’s cash, positions biotech to be among China’s CD47 leaders
...June 30, I-Mab had $221.1 million in cash and restricted cash.Other investors in the PIPE included
Avidity Partners
...
Read More
BioCentury
|
Aug 19, 2020
Finance
Aug. 18 Quick Takes: Chinook fuels up for NASDAQ liftoff; plus Kymera, Poseida, Albireo
...New investors in the kidney disease company include EcoR1 Capital, OrbiMed Advisors, Rock Springs Capital,
Avidity Partners
...
Read More
BioCentury
|
Jun 16, 2020
Finance
June 15 Quick Takes: RA makes $200M investment in Novavax; plus venture rounds for Shattuck, ImmVira, Glyscend and Shukun
...Group, with participation from new investors Janus Henderson Investors, Fidelity, EcoR1 Capital, Hatteras Venture Partners,
Avidity Partners
...
Read More
BioCentury
|
Jun 5, 2020
Finance
With $85M series B, Athira seeks to recover neuronal health in Alzheimer’s patients
...Capital, Highside Capital Management, Logos Capital, funds managed by Janus Henderson Investors, Sofinnova Investments and
Avidity Partners
...
Read More
BioCentury
|
Feb 28, 2020
Finance
Verastem raises $100M, plots path forward with targeted cancer combo
...The syndicate included RA Capital, Vivo Capital, Venrock, Farallon Capital Management, Acuta Capital, EcoR1 Capital,
Avidity Partners
...
Read More
Items per page:
10
1 - 9 of 9
Previous page
Next page